SOCIAL ANXIETY DISORDER (SAD)
Clinical trials for SOCIAL ANXIETY DISORDER (SAD) explained in plain language.
Never miss a new study
Get alerted when new SOCIAL ANXIETY DISORDER (SAD) trials appear
Sign up with your email to follow new studies for SOCIAL ANXIETY DISORDER (SAD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New therapy challenges standard anxiety treatment
Disease control Recruiting nowThis study is testing if a newer type of talk therapy, called transdiagnostic Metacognitive Therapy (tMCT), works better than the current standard therapy, Cognitive-Behavioral Therapy (CBT), for adults with anxiety disorders. It will involve 86 people in Sweden diagnosed with Ge…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Zapping anxiety: can brain stimulation ease social fears?
Disease control Recruiting nowThis study is testing whether a non-invasive brain stimulation technique can help reduce symptoms of social anxiety disorder. One hundred participants will receive either real or sham stimulation to the forehead area over one week. Researchers will track changes in anxiety levels…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Parent-Led therapy aims to bridge gap in youth mental health care
Disease control Recruiting nowThis study is testing a new, more accessible way to deliver therapy for childhood anxiety. It uses a 'stepped care' model where parents first learn skills through online materials to help their child, with more intensive therapist support available if needed. The goal is to provi…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: NA • Sponsor: Andrew Wiese • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New pill aims to ease social anxiety in major trial
Disease control Recruiting nowThis study is testing a new oral medication called NTX-1472 for adults with social anxiety disorder. About 100 participants will take either the drug or a placebo daily for 8 weeks to see if it safely reduces anxiety symptoms and improves daily functioning. Researchers will measu…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: PHASE2 • Sponsor: Newleos Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Sniff away stage fright? new nasal spray aims to calm social anxiety in minutes
Symptom relief Recruiting nowThis study is testing whether a nasal spray called fasedienol can quickly reduce anxiety symptoms when adults with social anxiety disorder face a public speaking challenge. About 236 participants will receive either the spray or a placebo during a simulated speech, and their anxi…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New therapy aims to help teens struggling with social fears and anger
Symptom relief Recruiting nowThis study is testing a type of talk therapy called Acceptance and Commitment Therapy (ACT) for teenagers who have social anxiety disorder or oppositional defiant disorder. The goal is to see if this single therapy approach can help reduce symptoms like intense social fear, disru…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: NA • Sponsor: University of Coimbra • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New anxiety pill tested for social stress relief
Symptom relief Recruiting nowThis study is testing whether a single dose of an experimental medication called VQW-765 can quickly reduce anxiety during stressful social situations. About 500 adults with social anxiety disorder will take either the medication or a placebo before a public speaking test. Resear…
Matched conditions: SOCIAL ANXIETY DISORDER (SAD)
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC